Exclusion criteria for deferred imaging and empiric rivaroxaban
| Factors with a higher risk of adverse effects of rivaroxaban . |
|---|
| Concomitant anticoagulation* |
| Suspected active or recent bleeding |
| Major risk factors for bleeding† |
| Active cancer or chemotherapy within the past 6 mo |
| Pregnancy or lactation |
| Hemoglobin <11 g/dL or thrombocytes <100 × 109/L |
| GFR <45 mL/min per 1.73 m2 |
| Liver disease with coagulopathy or other bleeding risk |
| Concomitant medications possibly interacting with rivaroxaban |
| Factors with a higher risk of adverse effects of rivaroxaban . |
|---|
| Concomitant anticoagulation* |
| Suspected active or recent bleeding |
| Major risk factors for bleeding† |
| Active cancer or chemotherapy within the past 6 mo |
| Pregnancy or lactation |
| Hemoglobin <11 g/dL or thrombocytes <100 × 109/L |
| GFR <45 mL/min per 1.73 m2 |
| Liver disease with coagulopathy or other bleeding risk |
| Concomitant medications possibly interacting with rivaroxaban |
| Conditions or situations in which scheduled workup is deemed inappropriate . |
|---|
| Suspicion of concurrent PE |
| Comorbidities necessitating admission |
| Suspected ischemia or eligibility for thrombolysis |
| Physician considers discharge unsafe |
| Patient objects to discharge |
| Logistical challenges |
| Workup can be completed within 2 h |
| Conditions or situations in which scheduled workup is deemed inappropriate . |
|---|
| Suspicion of concurrent PE |
| Comorbidities necessitating admission |
| Suspected ischemia or eligibility for thrombolysis |
| Physician considers discharge unsafe |
| Patient objects to discharge |
| Logistical challenges |
| Workup can be completed within 2 h |
Regular prescription or empiric anticoagulation for suspected DVT.
Current or recent gastrointestinal ulceration; presence of malignant neoplasms at high risk of bleeding; recent brain or spinal injury; recent brain, spinal, or ophthalmic surgery; recent intracranial hemorrhage; known or suspected esophageal varices; arteriovenous malformations; vascular aneurysms; major intraspinal, or intracerebral vascular abnormalities.